CELEX: 32021M10215
Language: en
Date: 2021-05-05 00:00:00
Title: Commission Decision of 05/05/2021 declaring a concentration to be compatible with the common market (Case No COMP/M.10215 - CVC / CARLYLE / MEDRISK) according to Council Regulation (EC) No 139/2004 (Only the English text is authentic)

EUROPEAN COMMISSION
                                                                Brussels, 05.05.2021
                                                                C(2021) 3302 final
                                                                                 PUBLIC VERSION
                                                                CVC Capital Partners SICAV-FIS S.A.
                                                                20 Avenue Monterey
                                                                L-2163 Luxembourg
                                                                Luxembourg
                                                                The Carlyle Group, Inc.
                                                                1001 Pennsylvania Avenue, NW
                                                                20004-2505 Washington, DC
                                                                United States of America
Subject:        Case M.10215 – CVC / CARLYLE / MEDRISK
                Commission decision pursuant to Article 6(1)(b) of Council Regulation
                                        1
                (EC) No 139/2004 and Article 57 of the Agreement on the European
                                    2
                Economic Area
Dear Sir or Madam,
1.      On 13 April 2021, the European Commission received notification of a proposed
        concentration pursuant to Article 4 of the Merger Regulation by which CVC Capital
        Partners SICAV-FIS S.A. (“CVC”, Luxembourg) and The Carlyle Group, Inc.
        (“Carlyle”, United States), acquire within the meaning of Article 3(1)(b) and Article
        3(4) of the Merger Regulation joint control over the whole of the undertaking
        MedRisk Holdco, LLC (“MedRisk”, United States), controlled by Carlyle, by way of
        purchase of shares.3
2.      The business activities of the undertakings concerned are:
             for CVC: management of investment funds and platforms holding interests in
              companies active in various industries primarily in Europe, United States, and the
              Asia-Pacific region,
1       OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’). With effect from 1 December 2009, the Treaty on
        the Functioning of the European Union (‘TFEU’) has introduced certain changes, such as the
        replacement of ‘Community’ by ‘Union’ and ‘common market’ by ‘internal market’. The terminology
        of the TFEU will be used throughout this decision.
2       OJ L 1, 3.1.1994, p. 3 (the ‘EEA Agreement’).
3       Publication in the Official Journal of the European Union No C 139, 20.4.2021, p. 5-6.
Commission européenne, DG COMP MERGER REGISTRY, 1049 Bruxelles, BELGIQUE
Europese Commissie, DG COMP MERGER REGISTRY, 1049 Brussel, BELGIË
Tel: +32 229-91111. Fax: +32 229-64301. E-mail: COMP-MERGER-REGISTRY@ec.europa.eu.
 ---pagebreak---       for Carlyle: global alternative asset manager of funds active globally across
       different investment disciplines, including corporate private equity, real estate,
       and natural resources funds,
      for MedRisk: supplier of managed physical therapy for the workers’
       compensation industry and related market sectors in the United States.
3. After examination of the notification, the European Commission has concluded that
   the notified operation falls within the scope of the Merger Regulation and paragraph
   5(a) of the Commission Notice on a simplified procedure for treatment of certain
   concentrations under Council Regulation (EC) No 139/2004. 4
4. For the reasons set out in the Notice on a simplified procedure, the European
   Commission has decided not to oppose the notified operation and to declare it
   compatible with the internal market and with the EEA Agreement. This decision is
   adopted in application of Article 6(1)(b) of the Merger Regulation and Article 57 of
   the EEA Agreement.
                                                   For the Commission
                                                   (Signed)
                                                   Olivier GUERSENT
                                                   Director-General
4  OJ C 366, 14.12.2013, p. 5.
                                              2